Oral SERD Camizestrant Prolongs PFS vs Fulvestrant in Breast Cancer
"The results of SERENA-2 support further development of camizestrant in ER-positive breast cancer."
Source: medscape.com
Pfizer Lilly News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pfizer Lilly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pfizer Lilly Today - Breaking & Trending Today